Prosecution Insights
Last updated: April 19, 2026

Examiner: CHEN, CATHERYNE

Tech Center 1600 • Art Units: 1655

This examiner grants 37% of resolved cases

Performance Statistics

36.9%
Allow Rate
-23.1% vs TC avg
817
Total Applications
+18.4%
Interview Lift
1689
Avg Prosecution Days
Based on 769 resolved cases, 2023–2026

Rejection Statute Breakdown

13.5%
§101 Eligibility
21.2%
§102 Novelty
40.2%
§103 Obviousness
16.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18088198 MATERIALS AND METHODS FOR BLOCKING MALARIA INFECTION AND TRANSMISSION Final Rejection THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES
18417731 COMPOSITIONS AND METHODS FOR IMPROVING MITOCHONDRIAL FUNCTION AND TREATING NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS Non-Final OA Amazentis SA
17292094 TREATMENT AND DIAGNOSIS OF AUTOANTIBODY-MEDIATED EYE DISEASES Non-Final OA THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
18042889 NEW SYSTEM WITH EMERGING PROPERTIES FOR USE IN THE TREATMENT OF METABOLIC SYNDROME Non-Final OA Aboca S.p.A. Società Agricola
18840761 THERAPEUTIC COMBINATIONS FOR INFLAMMATORY CONDITIONS AND DISORDERS Non-Final OA Native Code Bio, LLC
17966267 METHOD FOR LIBERATING INTRACELLULAR MATERIAL FROM PLANT CELLS Final Rejection Deerland Enzymes, Inc.
18637560 AGRICULTURAL COMPOSITIONS AND RELATED METHODS Non-Final OA SETATECH USA, INC.
18392701 COMPOSITION FOR IMPROVING, PREVENTING, OR TREATING SLEEP DISORDERS COMPRISING DENDROPANAX MORBIFERA EXTRACTS Non-Final OA JEJU NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
18444191 HERBAL SUPPLEMENTS AND METHODS OF USE THEREOF Non-Final OA KBS Research, LLC
18395764 METHODS FOR IMPROVING BONE QUALITY AND PROMOTING CARTILAGE DIFFERENTIATION BY CHRYSOPHYLLUM CAINITO EXTRACT AND MANUFACTURING METHOD THEREOF Non-Final OA TCI CO., LTD.
17290629 BIO-PESTICIDE OIL FORMULATION Non-Final OA Indian Oil Corporation Limited
18556692 COMPOSITION COMPRISING A PHYTOCOMPLEX FROM POMEGRANATE AND ITS USES Non-Final OA ESSERRE PHARMA SRL
17418003 Therapeutic Drug for Disease Accompanied by Disorders in Retinal Cells or Retinal Tissue Non-Final OA RACTHERA Co., Ltd.
18565815 COMPOSITION CONTAINING NATURAL PRODUCT-DERIVED ESSENTIAL OIL EXTRACT AS ACTIVE INGREDIENT FOR IMPROVING RESPIRATORY DISEASES Non-Final OA BOINBIO-CONVERGENCE CO., LTD.
18028097 COMPOSITION COMPRISING FLAVANOL MONOMERS AND E-VINIFERIN Non-Final OA ACTIV'INSIDE
18514609 NUTRACEUTICAL COMPOSITION AND METHOD FOR THE PROTECTION OF HUMAN ARTERIAL ENDOTHELIAL CELLS FROM ENDOTHELIAL CELL DYSFUNCTION Non-Final OA K.L.R.M., LLC
18511413 CHROMIUM CONTAINING COMPOSITIONS FOR IMPROVING HEALTH AND FITNESS Non-Final OA Nutrition21, LLC
17833297 SYSTEMS AND METHODS FOR MANUFACTURING API-CONTAINING EDIBLES, AND RESULTING EDIBLE PRODUCTS Final Rejection Transport Authority, Inc.
18287342 PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITION COMPRISING A MIXTURE OF PLANTS FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES Non-Final OA BIONEXX EUROPE
18558841 STABLE BIOACTIVE COMPOSITION Non-Final OA LINTBELLS LIMITED
18033964 MATRIX METALLOPROTEASE 1 EXPRESSION INHIBITOR, SKIN EXTERNAL AGENT, AND USE FOR INHIBITION OF MATRIX METALLOPROTEASE 1 EXPRESSION Non-Final OA DSR CORPORATION
18498563 FUNGAL COMPOUND COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATION Non-Final OA TURTLE BEAR HOLDINGS, LLC
18493383 CHELIDONIUM MAJUS EXTRACTS AND COMPOSITIONS Non-Final OA PHYTHERA THERAPEUTICS INC
16930564 COMPOSITIONS FOR TREATING OBESITY Final Rejection Truetiva, Inc.
18195895 METHOD TO HARVEST INSECTS, EGGS, AND LARVAE Final Rejection Lavaca River Ranch, LTD.
17164231 COMPOSITIONS OF BAKUCHIOL AND METHODS OF MAKING THE SAME Non-Final OA Unigen, Inc.
17997501 WINE LEES, DERIVATIVES THEREOF AND THEIR USES Non-Final OA GRANDES VINOS Y VIÑEDOS SA
18047098 EXTRACTION PROCESS Non-Final OA SPECNOVA LLC
17339662 NUTRITIONAL SUPPLEMENT TO EASE SIDE EFFECTS OF CANCER TREATMENT THERAPIES Final Rejection Marivation LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month